Martha Demski
Direttore/Membro del Consiglio presso CHIMERIX, INC.
Patrimonio netto: 140 576 $ in data 31/05/2024
Profilo
Martha J.
Demski is an Independent Director at Alpha Teknova, Inc. since 2023, Lead Independent Director at Chimerix, Inc. since 2005, and Independent Director at Equillium, Inc. since 2018.
Previously, she served as an Independent Director at ADMA Biologics, Inc. from 2020 to 2023, Independent Director at Adamas Pharmaceuticals LLC from 2014 to 2021, Independent Director at Neothetics, Inc. from 2014 to 2018, Director at Adamas Pharmaceuticals, Inc., Vice President at Bank of America Corp., Chief Financial Officer & Senior Vice President at Ajinomoto Althea, Inc. from 2011 to 2017, Chief Operating & Financial Officer at Sidney Kimmel Cancer Center from 2008 to 2010, Senior Vice President at US Trust in 2008, and Chief Financial Officer & Vice President at Vical, Inc. from 1988 to 2004.
Ms. Demski obtained an undergraduate degree from Michigan State University and an MBA from The University of Chicago Booth School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CHIMERIX, INC.
0.08% | 20/06/2024 | 72 055 ( 0.08% ) | 69 677 $ | 31/05/2024 |
EQUILLIUM, INC.
0.07% | 22/05/2024 | 23 799 ( 0.07% ) | 35 699 $ | 31/05/2024 |
ALPHA TEKNOVA, INC.
0.05% | 26/06/2024 | 20 000 ( 0.05% ) | 35 200 $ | 31/05/2024 |
Posizioni attive di Martha Demski
| Società | Posizione | Inizio |
|---|---|---|
| CHIMERIX, INC. | Direttore/Membro del Consiglio | 01/08/2023 |
| EQUILLIUM, INC. | Direttore/Membro del Consiglio | 01/09/2018 |
| ALPHA TEKNOVA, INC. | Direttore/Membro del Consiglio | 31/08/2023 |
Precedenti posizioni note di Martha Demski
| Società | Posizione | Fine |
|---|---|---|
| ADMA BIOLOGICS, INC. | Direttore/Membro del Consiglio | 06/06/2023 |
| ADAMAS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 24/11/2021 |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/01/2018 |
Ajinomoto Althea, Inc.
 Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | 01/05/2017 |
Sidney Kimmel Cancer Center
 Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Direttore Finanziario/CFO | 01/12/2010 |
Formazione di Martha Demski
| Michigan State University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| EQUILLIUM, INC. | Health Technology |
| ADMA BIOLOGICS, INC. | Health Technology |
| ALPHA TEKNOVA, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
| US Trust | Finance |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Health Services |
| Adamas Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Martha Demski
